United States

KPC Pharmaceuticals Inc (600422.SS)

600422.SS on Shanghai Stock Exchange

15 Dec 2017
Change (% chg)

¥0.36 (+3.89%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Chart for


KPC Pharmaceuticals, Inc. is a China-based company principally engaged in the research and development, manufacturing and sales of pharmaceuticals. The Company's main products include natural herbal medicines, traditional Chinese medicines and chemical synthetic drugs, such as central nervous system drugs, cardiovascular and... (more)


Beta: 0.70
Market Cap(Mil.): ¥7,563.52
Shares Outstanding(Mil.): 788.69
Dividend: 0.18
Yield (%): 1.88


  Industry Sector
P/E (TTM): -- 32.20 16.04
EPS (TTM): -- -- --
ROI: -- 15.06 34.69
ROE: -- 16.55 15.46

BRIEF-KPC Pharmaceuticals unit to buy 60 pct stake in Dali-based pharma for 18 mln yuan

* Says its unit plans to use 18 million yuan to buy a 60 percent stake in a Dali-based pharmaceutical company

Sep 04 2017

BRIEF-KPC Pharmaceuticals sells land action worth 19.6 mln yuan

* Says it sold land action worth 19.6 million yuan to a tourism land mineral reserve center

Aug 29 2017

BRIEF-KPC pharmaceuticals' H1 net profit down 13.2 pct y/y

Aug 18 KPC Pharmaceuticals Inc * Says H1 net profit down 13.2 percent y/y Source text in Chinese: http://bit.ly/2uO26LD Further company coverage: (Reporting by Hong Kong newsroom)

Aug 18 2017

BRIEF-KPC Pharmaceuticals's shareholder plans to unload up to 25 pct stake in co within six months

* Says shareholder Yuan Dongping plans to unload up to 25 percent stake in the co within six months

Aug 02 2017

BRIEF-KPC Pharmaceuticals unit plans medical JV worth 10 mln yuan with partner

* Says its unit plans to use 8.2 million yuan to set up a medical JV with partner in Yuxi city

Jul 03 2017

Earnings vs. Estimates